Doxorubicin-induced cardiotoxicity: an overview on pre-clinical therapeutic approaches M Sheibani, Y Azizi, M Shayan, S Nezamoleslami, F Eslami, MH Farjoo, ... Cardiovascular Toxicology 22 (4), 292-310, 2022 | 84 | 2022 |
Recent advances on drug-loaded mesenchymal stem cells with anti-neoplastic agents for targeted treatment of cancer A Babajani, P Soltani, E Jamshidi, MH Farjoo, H Niknejad Frontiers in bioengineering and biotechnology 8, 748, 2020 | 81 | 2020 |
The cross-talks among bone morphogenetic protein (BMP) signaling and other prominent pathways involved in neural differentiation A Manzari-Tavakoli, A Babajani, MH Farjoo, M Hajinasrollah, S Bahrami, ... Frontiers in Molecular Neuroscience 15, 827275, 2022 | 27 | 2022 |
Ascorbic Acid interaction with analgesic effect of morphine and tramadol in mice F Zeraati, M Araghchian, MH Farjoo Anesthesiology and pain medicine 4 (3), 2014 | 26 | 2014 |
Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic inflammation A Babajani, K Moeinabadi-Bidgoli, F Niknejad, H Rismanchi, S Shafiee, ... Stem Cell Research & Therapy 13 (1), 126, 2022 | 15 | 2022 |
Therapeutic properties of stem cell-derived exosomes in ischemic heart disease NR Dehkordi, NR Dehkordi, MH Farjoo European Journal of Pharmacology 920, 174839, 2022 | 14 | 2022 |
Related fluoxetine and methylprednisolone changes of TNF-α and IL-6 expression in the hypothyroidism rat model of spinal cord injury A Zirak, M Soleimani, SB Jameie, MA Abdollahifar, FF Fathabadi, ... Cell Journal (Yakhteh) 23 (7), 763, 2021 | 8 | 2021 |
Pre-clinical safety and therapeutic efficacy of a plant-based alkaloid in a human colon cancer xenograft model JL Freeling, JL Scholl, M Eikanger, C Knoblich, RA Potts, DJ Anderson, ... Cell Death Discovery 8 (1), 135, 2022 | 7 | 2022 |
MMP inhibition as a novel strategy for extracellular matrix preservation during whole liver decellularization M Kasravi, A Yaghoobi, T Tayebi, M Hojabri, AT Taheri, F Shirzad, ... Biomaterials Advances 156, 213710, 2024 | 4 | 2024 |
Artificial intelligence in diagnosis of long QT syndrome: a review of current state, challenges, and future perspectives NR Dehkordi, NR Dehkordi, KK Toudeshki, MH Farjoo Mayo Clinic Proceedings: Digital Health 2 (1), 21-31, 2024 | 3 | 2024 |
Alpha-pinene preserves human dopaminergic SH-SY5Y cells against 6-hydroxydopamine-induced toxicity through its antioxidant and antiapoptotic properties and gamma-aminobutyric … M Moshrefi, AM Pourrahimi, M Abbasnejad, MH Farjoo, ... Biomedical and Biotechnology Research Journal (BBRJ) 6 (2), 255-260, 2022 | 2 | 2022 |
Reply to: Exercise Testing and Artificial Intelligence as Allies in Improving the Detection and Diagnosis of Long QT Syndrome NR Dehkordi, NR Dehkordi, KK Toudeshki, MH Farjoo Mayo Clinic Proceedings: Digital Health 2 (1), 164, 2024 | | 2024 |
Assessment of Hemoglobin A1c Management and Prescription Cost Due to Polypharmacy Among Patients With Diabetes in Iran Based on the STEPS Iran 2016 Survey and a Prescription … M Daneshmand, H Jamshidi, MH Farjoo, MR Malekpour, E Ghasemi, ... Archives of Iranian Medicine 27 (1), 1, 2024 | | 2024 |
Inhibition of EGF and CoCl2-induced HIF-1α and VEGF production in triple negative MDA-MB-468 cells by umbelliprenin: unveiling the role of PI3K/AKT/mTOR and MAPK pathways R Atabakhshian, M Moshirpour, MH Farjoo, S Ghafghazi Research Journal of Pharmacognosy 11 (1), 19-31, 2024 | | 2024 |
Epidemiology of Polypharmacy, Drug-drug Interaction, and Potentially Inappropriate Medication Among Metabolic Syndrome Patients in Iran: A National, Cross-sectional, Multi … M Daneshmand, H Jamshidi, MR Malekpour, E Ghasemi, SS Moghaddam, ... | | 2023 |
Assessment of Cost and Diabetes Management Due to Polypharmacy in Iran Based on Haemoglobin A1c Levels, A Cross Sectional National Study M Daneshmand, F Farzadfar, H Jamshidi, SS Mortazavi, M Shati, ... | | 2023 |
Epidemiology assessment of poly-pharmacy among metabolic syndrome patients based on prescriptions of Iranians health insurance service data sets, a cross sectional study M Daneshmand, H Jamshidi, F Farzadfar, MH Farjoo, S Mortazavi, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 177-178, 2022 | | 2022 |
A glance into the Pathology of Covid-19, Its Current and Possible Treatments; Interleukin Antagonists as an Effective Option; A review. M Daneshmand, MH Farjoo School of Medicine Students' Journal 3 (2), 2-10, 2020 | | 2020 |
Recent advances in placenta-derived mesenchymal stem cells and their exosomes in cancer therapy HN E. Jamshidi, P. Soltani2,3, M. Abbasi-Kangevari, M. H. Farjoo Tissue Engineering and Regenerative Medicine, 2019 | | 2019 |
Exosomes in diagnosis and therapy of cardiovascular diseases. Hype or hope? HN K. Amirzadeh gougheri , M.H. Farjoo Tissue Engineering and Regenerative Medicine, 2019 | | 2019 |